Evolva: Swiss Watchmaker

The chemistry bottleneck in drug discovery is defined by the time and cost required to identify and synthesize new compounds. Evolva Ltd. says its Watchmaker yeast-based technology helps it discover compounds faster than traditional high throughput screening and medicinal chemistry methods. The company adds that it also can create compounds that are hard to make using other techniques.

Watchmaker introduces hundreds of genes into yeast and uses the innate evolutionary power of these cells to perform high throughput drug discovery and lead optimization. ...